180 related articles for article (PubMed ID: 26124979)
1. HIV-associated neurocognitive disorders: Five new things.
Rumbaugh JA; Tyor W
Neurol Clin Pract; 2015 Jun; 5(3):224-231. PubMed ID: 26124979
[TBL] [Abstract][Full Text] [Related]
2. Changing clinical phenotypes of HIV-associated neurocognitive disorders.
Sacktor N
J Neurovirol; 2018 Apr; 24(2):141-145. PubMed ID: 28752495
[TBL] [Abstract][Full Text] [Related]
3. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
[TBL] [Abstract][Full Text] [Related]
4. Multimodal Approach to Neurocognitive Function in People Living with HIV in the cART Era: A Comprehensive Review.
Moschopoulos CD; Stanitsa E; Protopapas K; Kavatha D; Papageorgiou SG; Antoniadou A; Papadopoulos A
Life (Basel); 2024 Apr; 14(4):. PubMed ID: 38672778
[TBL] [Abstract][Full Text] [Related]
5. Validation of the International HIV Dementia Scale as a Screening Tool for HIV-Associated Neurocognitive Disorders in a German-Speaking HIV Outpatient Clinic.
Marin-Webb V; Jessen H; Kopp U; Jessen AB; Hahn K
PLoS One; 2016; 11(12):e0168225. PubMed ID: 27992497
[TBL] [Abstract][Full Text] [Related]
6. Evolving clinical phenotypes in HIV-associated neurocognitive disorders.
Sacktor N; Robertson K
Curr Opin HIV AIDS; 2014 Nov; 9(6):517-20. PubMed ID: 25203640
[TBL] [Abstract][Full Text] [Related]
7. HIV-Associated Neurocognitive Disorder (HAND) and the Prospect of Brain-Penetrating Protease Inhibitors for Antiretroviral Treatment.
Ghosh AK; Sarkar A; Mitsuya H
Med Res Arch; 2017 Apr; 5(4):. PubMed ID: 29984302
[TBL] [Abstract][Full Text] [Related]
8. Motor function declines over time in human immunodeficiency virus and is associated with cerebrovascular disease, while HIV-associated neurocognitive disorder remains stable.
M Elicer I; Byrd D; Clark US; Morgello S; Robinson-Papp J
J Neurovirol; 2018 Aug; 24(4):514-522. PubMed ID: 29696578
[TBL] [Abstract][Full Text] [Related]
9. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients.
Ciccarelli N; Fabbiani M; Di Giambenedetto S; Fanti I; Baldonero E; Bracciale L; Tamburrini E; Cauda R; De Luca A; Silveri MC
Neurology; 2011 Apr; 76(16):1403-9. PubMed ID: 21502598
[TBL] [Abstract][Full Text] [Related]
10. A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.
Vassallo M; Fabre R; Durant J; Lebrun-Frenay C; Joly H; Ticchioni M; DeSalvador F; Harvey-Langton A; Dunais B; Laffon M; Cottalorda J; Dellamonica P; Pradier C
J Neurovirol; 2017 Apr; 23(2):216-225. PubMed ID: 27815816
[TBL] [Abstract][Full Text] [Related]
11. Neurological soft signs as a marker of cognitive impairment severity in people living with HIV.
Toro P; Ceballos ME; Pesenti J; Inostroza M; Valenzuela D; Henríquez F; Forno G; Herold C; Schröder J; Calderón J
Psychiatry Res; 2018 Aug; 266():138-142. PubMed ID: 29870954
[TBL] [Abstract][Full Text] [Related]
12. Neuroimaging of HIV-associated neurocognitive disorders.
Haziot MEJ; Barbosa Junior SP; Vidal JE; de Oliveira FTM; de Oliveira ACP
Dement Neuropsychol; 2015; 9(4):380-384. PubMed ID: 29213987
[TBL] [Abstract][Full Text] [Related]
13. Association of age and time of disease with HIV-associated neurocognitive disorders: a Japanese nationwide multicenter study.
Kinai E; Komatsu K; Sakamoto M; Taniguchi T; Nakao A; Igari H; Takada K; Watanabe A; Takahashi-Nakazato A; Takano M; Kikuchi Y; Oka S;
J Neurovirol; 2017 Dec; 23(6):864-874. PubMed ID: 28971376
[TBL] [Abstract][Full Text] [Related]
14. Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.
Vassallo M; Durant J; Lebrun-Frenay C; Fabre R; Ticchioni M; Andersen S; DeSalvador F; Harvey-Langton A; Dunais B; Cohen-Codar I; Montagne N; Cua E; Fredouille-Heripret L; Laffon M; Cottalorda J; Dellamonica P; Pradier C
HIV Med; 2015 Aug; 16(7):431-40. PubMed ID: 25981452
[TBL] [Abstract][Full Text] [Related]
15. Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection.
Nichols MJ; Gates TM; Soares JR; Moffat KJ; Rae CD; Brew BJ; Cysique LA
AIDS; 2019 Jan; 33(1):55-66. PubMed ID: 30325766
[TBL] [Abstract][Full Text] [Related]
16. HIV-Associated Neurologic Disorders and Central Nervous System Opportunistic Infections in HIV.
Le LT; Spudich SS
Semin Neurol; 2016 Aug; 36(4):373-81. PubMed ID: 27643907
[TBL] [Abstract][Full Text] [Related]
17. HIV-associated neurocognitive disorders (HAND).
Elbirt D; Mahlab-Guri K; Bezalel-Rosenberg S; Gill H; Attali M; Asher I
Isr Med Assoc J; 2015 Jan; 17(1):54-9. PubMed ID: 25739180
[TBL] [Abstract][Full Text] [Related]
18. Optimal treatment of HIV-associated neurocognitive disorders: myths and reality. A critical review.
Bougea A; Spantideas N; Galanis P; Gkekas G; Thomaides T
Ther Adv Infect Dis; 2019; 6():2049936119838228. PubMed ID: 31001421
[TBL] [Abstract][Full Text] [Related]
19. Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand.
Heaps JM; Sithinamsuwan P; Paul R; Lerdlum S; Pothisri M; Clifford D; Tipsuk S; Catella S; Busovaca E; Fletcher JL; Raudabaugh B; Ratto-Kim S; Valcour V; Ananworanich J;
J Neurovirol; 2015 Apr; 21(2):105-12. PubMed ID: 25604494
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
